Alex Zhavoronkov - CEO Insilico Medicine

In this episode of Life Science Success my Guest is Alex Zhavoronkov.  Alex is the CEO Insilico Medicine an AI-powered drug discovery company.

• Insilico Medicine has progressed three internally-derived assets into human clinical trials.

• Insilico Medicine has discovered over 30 other programs in different stages.
• Insilico Medicine incorporates three engines in their platform: biology, chemistry, and clinical.
• They generate normal molecules with desired properties using 42 generative engines.
• They have a system that predicts clinical trials outcomes.
• Insilico Medicine’s main strategy is partnering with pharma companies at the preclinical candidate stage.
• They value patient first, relentless innovation, and transparency and integrity.
• Alex's biggest concern is human tendency to prioritize unimportant things over important ones.
• Alex is excited about large language models, multimodal generative AI, robotics, and quantum computing.

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.